-
1.发明公开
公开(公告)号：EP2049500A1
公开(公告)日：2009-04-22
申请号：EP07799329.3
申请日：2007-07-05
发明人： MITCHELL, Ian S. , BLAKE, James F. , XU, Rui , KALLAN, Nicholas C. , XIAO, Dengming , SPENCER, Keith Lee , BENCSIK, Josef R. , LIANG, Jun , SAFINA, Brian , LI, Jun , CHABOT, Christine , BANKA, Anna.L. , WALLACE, Eli. M. , SCHLACHTER, Stephen.T.
IPC分类号： C07D239/70 , C07D401/12 , C07D403/04 , C07D403/12 , C07D407/12 , C07D409/12 , C07D409/14 , A61K31/517 , A61P35/00
CPC分类号： C07D409/14 , A61K31/517 , A61K31/5377 , A61K45/06 , C07D239/70 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/12 , C07D409/12
摘要： The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Formula (I). Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
-
2.发明公开HYDROXYLATED AND METHOXYLATED CYCLOPENTA [D] PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS 审中-公开羟肟酸甲氧基环戊二烯[D] - 吡啶ALS AKT-蛋白酶
公开(公告)号：EP2966065A2
公开(公告)日：2016-01-13
申请号：EP15178003.8
申请日：2007-07-05
发明人： MITCHELL, Ian, S. , BLAKE, James, F. , XU, Rui , KALLAN, Nicholas, C. , XIAO, Dengming , SPENCER, Keith, Lee , BENCSIK, Josef, R. , LIANG, Jun , SAFINA, Brian , ZHANG, Birong , CHABOT, Christine , DO, Steven , WALLACE, Eli, W. , BANKA, Anna, L. , SCHLACHTER, Stephen, T.
IPC分类号： C07D239/70 , C07D401/12 , C07D403/04 , C07D403/12 , C07D407/12 , C07D409/12 , C07D409/14 , A61K31/517 , A61P35/00
CPC分类号： C07D239/70 , C07D401/12 , C07D403/04 , C07D403/12 , C07D407/12 , C07D409/12 , C07D409/14
摘要： The present invention provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula I for use in oral dosage forms:
Also provided are oral dosage forms comprising these compounds, methods of using the compounds and oral dosage forms of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer. Further provided are intermediate compounds from the synthesis of these compounds.摘要翻译： 本发明提供包含拆分的对映异构体，分解的非对映异构体，溶剂化物和药学上可接受的盐的化合物，其包含用于口服剂型的式I：还提供包含这些化合物的口服剂型，使用该化合物的方法和口服剂型 的本发明作为AKT蛋白激酶抑制剂和用于治疗过度增殖性疾病如癌症。 还提供了来自这些化合物的合成的中间体化合物。
-
公开(公告)号：EP2173723B3
公开(公告)日：2014-11-19
申请号：EP08781340.8
申请日：2008-07-03
发明人： BENCSIK, Josef, R. , BLAKE, James, F. , KALLAN, Nicholas, C. , MITCHELL, Ian, S. , SPENCER, Keith, L. , XIAO, Dengming , XU, Rui , CHABOT, Christine , LIANG, Jun , SAFINA, Brian, S.
IPC分类号： C07D239/70 , A61K31/517 , A61P35/00
CPC分类号： C07D239/70 , C07D401/12 , C07D403/12 , C07D409/12
-
4.发明授权CYCLOPENTA [D] PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS 有权环磷酰胺[D] - 吡咯烷酮AKT-PROTEINKINASEHEMMER
公开(公告)号：EP2049500B1
公开(公告)日：2011-09-07
申请号：EP07799329.3
申请日：2007-07-05
发明人： MITCHELL, Ian S. , BLAKE, James F. , XU, Rui , KALLAN, Nicholas C. , XIAO, Dengming , SPENCER, Keith Lee , BENCSIK, Josef R. , LIANG, Jun , SAFINA, Brian , LI, Jun , CHABOT, Christine , BANKA, Anna.L. , WALLACE, Eli. M. , SCHLACHTER, Stephen.T.
IPC分类号： C07D239/70 , C07D401/12 , C07D403/04 , C07D403/12 , C07D407/12 , C07D409/12 , C07D409/14 , A61K31/517 , A61P35/00
CPC分类号： C07D409/14 , A61K31/517 , A61K31/5377 , A61K45/06 , C07D239/70 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/12 , C07D409/12
摘要： The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Formula (I). Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
-
5.发明授权HYDROXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS 有权羟基化PYRIMIDYLCYCLOPENTANE AS AKT蛋白激酶抑制剂
公开(公告)号：EP2247578B1
公开(公告)日：2013-05-22
申请号：EP09700422.0
申请日：2009-01-09
发明人： BENCSIK, Josef R. , BLAKE, James F. , KALLAN, Nicholas C. , MITCHELL, Ian S. , SPENCER, Keith Lee , XIAO, Dengming , XU, Rui , CHABOT, Christine , DO, Steven , LIANG, Jun , SAFINA, Brian , ZHANG, Birong
IPC分类号： C07D239/70 , A61K31/517 , A61P35/00
CPC分类号： C07D239/70
-
6.发明公开HYDROXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS 有权羟丙基吡嗪基胆碱酯酶AKT-PROTEINKINASEINHIBITOREN
公开(公告)号：EP2247578A1
公开(公告)日：2010-11-10
申请号：EP09700422.0
申请日：2009-01-09
发明人： BENCSIK, Josef R. , BLAKE, James F. , KALLAN, Nicholas C. , MITCHELL, Ian S. , SPENCER, Keith Lee , XIAO, Dengming , XU, Rui , CHABOT, Christine , DO, Steven , LIANG, Jun , SAFINA, Brian , ZHANG, Birong
IPC分类号： C07D239/70 , A61K31/517 , A61P35/00
CPC分类号： C07D239/70
摘要： The present invention provides compounds, including pharmaceutically acceptable salts thereof, comprising the Formula (I): Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases, such as cancer.
-
公开(公告)号：EP2173723A1
公开(公告)日：2010-04-14
申请号：EP08781340.8
申请日：2008-07-03
发明人： BENCSIK, Josef, R. , BLAKE, James, F. , KALLAN, Nicholas, C. , MITCHELL, Ian, S. , SPENCER, Keith, L. , XIAO, Dengming , XU, Rui , CHABOT, Christine , LIANG, Jun , SAFINA, Brian, S.
IPC分类号： C07D239/70 , A61K31/517 , A61P35/00
CPC分类号： C07D239/70 , C07D401/12 , C07D403/12 , C07D409/12
摘要： The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
摘要翻译： 本发明提供式I的化合物，包括其互变异构体，拆分的对映异构体，非对映异构体，溶剂化物，代谢物，盐和药学上可接受的前药。 还提供了使用本发明化合物作为AKT蛋白激酶抑制剂并用于治疗过度增殖性疾病如癌症的方法。
-
8.发明公开HYDROXYLATED AND METHOXYLATED CYCLOPENTA [D] PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS 审中-公开羟基化和甲氧基环戊二烯基[D]嘧啶作为AKT蛋白激酶抑制剂
公开(公告)号：EP2966065A3
公开(公告)日：2016-03-02
申请号：EP15178003.8
申请日：2007-07-05
发明人： MITCHELL, Ian, S. , BLAKE, James, F. , XU, Rui , KALLAN, Nicholas, C. , XIAO, Dengming , SPENCER, Keith, Lee , BENCSIK, Josef, R. , LIANG, Jun , SAFINA, Brian , ZHANG, Birong , CHABOT, Christine , DO, Steven , WALLACE, Eli, W. , BANKA, Anna, L. , SCHLACHTER, Stephen, T.
IPC分类号： C07D239/70 , C07D401/12 , C07D403/04 , C07D403/12 , C07D407/12 , C07D409/12 , C07D409/14 , A61K31/517 , A61P35/00
CPC分类号： C07D239/70 , C07D401/12 , C07D403/04 , C07D403/12 , C07D407/12 , C07D409/12 , C07D409/14
摘要： The present invention provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula I for use in oral dosage forms:
Also provided are oral dosage forms comprising these compounds, methods of using the compounds and oral dosage forms of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer. Further provided are intermediate compounds from the synthesis of these compounds.摘要翻译： 本发明提供了包含用于口服剂型的式I的化合物，包括拆分的对映体，拆分的非对映体，溶剂化物和药学上可接受的盐：还提供了包含这些化合物的口服剂型，使用该化合物的方法和口服剂型 作为AKT蛋白激酶抑制剂用于治疗过度增殖性疾病如癌症。 进一步提供了来自合成这些化合物的中间体化合物。
-
9.发明授权HYDROXYLATED PYRIMIDYL CYCLOPENTANE AS AKT PROTEIN KINASE INHIBITOR 有权羟丙基吡咯烷基环丙烷酸AKT-PROTEINKINASEHEMMER
公开(公告)号：EP2240455B1
公开(公告)日：2012-12-26
申请号：EP09700629.0
申请日：2009-01-09
发明人： BENCSIK, Josef , BLAKE, James, F. , KALLAN, Nicholas, C. , MITCHELL, Ian, S. , SPENCER, Keith, L. , XIAO, Dengming , XU, Rui , CHABOT, Christine , DO, Steven , LIANG, Jun , SAFINA, Brian , ZHANG, Birong
IPC分类号： C07D239/70 , A61K31/517 , A61P35/00
CPC分类号： C07D239/70
-
10.发明公开HYDROXYLATED PYRIMIDYL CYCLOPENTANE AS AKT PROTEIN KINASE INHIBITOR 有权羟基化pyrimidylaminoquinoline环戊烷AS AKT蛋白激酶抑制剂
公开(公告)号：EP2240455A1
公开(公告)日：2010-10-20
申请号：EP09700629.0
申请日：2009-01-09
发明人： BENCSIK, Josef , BLAKE, James, F. , KALLAN, Nicholas, C. , MITCHELL, Ian, S. , SPENCER, Keith, L. , XIAO, Dengming , XU, Rui , CHABOT, Christine , DO, Steven , LIANG, Jun , SAFINA, Brian , ZHANG, Birong
IPC分类号： C07D239/70 , A61K31/517 , A61P35/00
CPC分类号： C07D239/70
摘要： The present invention provides a compound and pharmaceutically acceptable salts thereof, comprising the Formula I. Also provided are methods of using the compound of this invention as an AKT protein kinase inhibitor and for the treatment of hyperproliferative diseases such as cancer.
-
-
-
-
-
-
-
-
-
搜索结果
13 条记录 (耗时 0.018 秒)
